 SAN DIEGO, Nov. 23, 2020 PRNewswire -- Halozyme Therapeutics, Inc. NASDAQ: HALO today announced that it is updating 2020 financial guidance to reflect the signing of a global collaboration and license agreement with Horizon Therapeutics plc. The Company is raising full year 2020... 